Novel insights into the effects of inducible nitric oxide synthase inhibition during sepsis

Critical Care Medicine

Volumn 36, Issue 1, 2008, Pages 359-360

  Preiser, Jean Charles ^a   De Backer, Daniel ^b  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b ERASME HOSPITAL   (Belgium)

Author keywords

Cecal ligation and puncture; l N iminoethyl lysine; Microcirculation; Oxygen metabolism; Rat model; Septic shock

Indexed keywords

DOBUTAMINE; ENZYME INHIBITOR; GROWTH HORMONE; INDUCIBLE NITRIC OXIDE SYNTHASE; N IMINOETHYLLYSINE; UNCLASSIFIED DRUG;

BLOOD FLOW; EDITORIAL; ENZYME INHIBITION; INTENSIVE CARE UNIT; LIGATION; OXYGEN CONSUMPTION; OXYGEN DELIVERY DEVICE; OXYGEN SATURATION; OXYGENATION; PLEIOTROPY; PRIORITY JOURNAL; PUNCTURE; SEPSIS;

EID: 37549018889     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000297947.51539.8F     Document Type: Editorial

References (20)

1. Bateman RM, Sharpe MD, Goldman D, et al: Inhibiting nitric oxide overproduction during hypotensive sepsis increases local oxygen consumption in rat skeletal muscle. Crit Care Med 2008; 36:225-231
2. Vincent JL, Zhang H, Szabo C, et al: Effects of nitric oxide in septic shock. Am J Respir Crit Care Med 2000; 161:1781-1785
3. Preiser JC: Role of nitric oxide in cardiovascular alterations. Sepsis 2000; 4:99-109
4. Lopez A, Lorente JA, Steingrub J, et al: Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: Effect on survival in patients with septic shock. Crit Care Med 2004; 32:21-30
5. Watson D, Grover R, Anzueto A, et al: Cardiovascular effects of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochloride (546C88) in patients with septic shock: Results of a randomized, doubleblind, placebo-controlled multicenter study. Crit Care Med 2004; 32:13-20
6. Bakker J, Grover R, McLuckie A, et al: Administration of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochloride (546C88) by intravenous infusion for up to 72 hours can promote the resolution of shock in patients with severe sepsis: Results of a randomized, double-blind, placebo-controlled multicenter study. Crit Care Med 2004; 2:1-12
7. De Backer D, Creteur J, Preiser JC, et al: Microvascular blood flow is altered in patients with sepsis. Am J Respir Crit Care Med 2002; 166:98-104
8. Boerma EC, Van der Voort PH, Spronk PE, et al: Relationship between sublingual and intestinal microcirculatory perfusion in patients with abdominal sepsis. Crit Care Med 2007; 35:1055-1060
9. Bateman RM, Sharpe MD, Ellis CG: Bench-to-bedside review: Microvascular dysfunction in sepsis - Hemodynamics, oxygen transport, and nitric oxide. Crit Care 2003; 7:359-373
10. Bateman RM, Tokunaga C, Kareco T, et al: Myocardial hypoxia-inducible HIF-1alpha, VEGF, and GLUT1 gene expression is associated with microvascular and ICAM-1 heterogeneity during endotoxemia. Am J Physiol Heart Circ Physiol 2007; 293:H448-H456
11. Hollenberg SM, Broussard M, Osman J, et al: Increased microvascular reactivity and improved mortality in septic mice lacking inducible nitric oxide synthase. Circ Res 2000; 86:774-778
12. Matejovic M, Krouzecky A, Martinkova V, et al: Selective inducible nitric oxide synthase inhibition during long-term hyperdynamic porcine bacteremia. Shock 2004; 21:458-465
13. Wu L, Mayeux PR: Effects of the inducible nitric-oxide synthase inhibitor L-N(6)-(1-iminoethyl)-lysine on microcirculation and reactive nitrogen species generation in the kidney following lipopolysaccharide administration in mice. J Pharmacol Exp Ther 2007; 320:1061-1067
14. Sakr Y, Dubois MJ, De Backer D: Persistent microcirculatory alterations are associated with organ failure and death in patients with septic shock. Crit Care Med 2004; 32:1825-1831
15. Doerschug KC, Delsing AS, Schmidt GA, et al: Impairments in microvascular reactivity are related to organ failure in human sepsis. Am J Physiol Heart Circ Physiol 2007; 293:H1065-H1071
16. Hayes DF, Timmins AC, Yau EH, et al: Elevation of systemic oxygen delivery in the treatment of critically ill patients. N Engl J Med 1994; 330:1717-1722
17. Takala J, Ruokonen E, Webster NR, et al: Increased mortality associated with growth hormone treatment in critically ill adults. N Engl J Med 1999; 341:785-792
18. De Backer D, Hollenberg S, Boerma C, et al: How to evaluate the microcirculation? Report of a round table conference. Crit Care 2007; 11:R101
19. Scott JA, Mehta S, Dugan M, et al: Functional inhibition of constitutive nitric oxide synthase in a rat model of sepsis. Am J Respir Crit Care Med 2002; 165:1426-1432
20. Spronk PE, Gardien, Ince C, et al: Nitroglycerin in septic shock after intravascular volume resuscitation. Lancet 2002; 360:1395-1396